Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP

Osawa, I., Akita, K., Hasegawa, K., Fifer, M. A., Tower-Rader, A., Reilly, M. P., Maurer, M. S., Stitziel, N. O., Javaheri, A., & Shimada, Y. J. (2025). Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.124.012343
Authors:
Itsuki Osawa
Keitaro Akita
Kohei Hasegawa
Michael A Fifer
Albree Tower-Rader
Muredach P Reilly
Mathew S Maurer
Nathan O Stitziel
Ali Javaheri
Yuichi J Shimada
Affiliated Authors:
Itsuki Osawa
Keitaro Akita
Muredach P Reilly
Mathew S Maurer
Yuichi J Shimada
Columbia Affiliation:
Author Keywords:
biomarker
cardiomyopathy, hypertrophic
cardiovascular diseases
heart failure
proteomics
cardiomyopathy
hypertrophic
elink
Publication Type:
Article
Unique ID:
10.1161/circheartfailure.124.012343
PMID:
39831317
DOI:
10.1161/circheartfailure.124.012343
Journal:
Circulation: Heart Failure
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: